The Market Reports

Index

1 Sofosbuvir (CAS 1190307-88-0) Market Overview
1.1 Product Overview and Scope of Sofosbuvir (CAS 1190307-88-0)
1.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type
1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate Analysis by Type 2021 VS 2027
1.2.2 Purity ≥ 98%
1.2.3 Purity ＜ 98%
1.3 Sofosbuvir (CAS 1190307-88-0) Segment by Application
1.3.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Comparison by Application: 2016 VS 2021 VS 2027
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Global Market Growth Prospects
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue Estimates and Forecasts (2016-2027)
1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Estimates and Forecasts (2016-2027)
1.4.3 Global Sofosbuvir (CAS 1190307-88-0) Production Estimates and Forecasts (2016-2027)
1.5 Global Sofosbuvir (CAS 1190307-88-0) Market by Region
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
1.5.2 North America Sofosbuvir (CAS 1190307-88-0) Estimates and Forecasts (2016-2027)
1.5.3 Europe Sofosbuvir (CAS 1190307-88-0) Estimates and Forecasts (2016-2027)
1.5.5 China Sofosbuvir (CAS 1190307-88-0) Estimates and Forecasts (2016-2027)
1.5.5 Japan Sofosbuvir (CAS 1190307-88-0) Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers
2.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturers (2016-2021)
2.3 Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Sofosbuvir (CAS 1190307-88-0) Average Price by Manufacturers (2016-2021)
2.5 Manufacturers Sofosbuvir (CAS 1190307-88-0) Production Sites, Area Served, Product Types
2.6 Sofosbuvir (CAS 1190307-88-0) Market Competitive Situation and Trends
2.6.1 Sofosbuvir (CAS 1190307-88-0) Market Concentration Rate
2.6.2 Global 5 and 10 Largest Sofosbuvir (CAS 1190307-88-0) Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region
3.1 Global Production Capacity of Sofosbuvir (CAS 1190307-88-0) Market Share by Region (2016-2021)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2016-2021)
3.3 Global Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Price and Gross Margin (2016-2021)
3.4 North America Sofosbuvir (CAS 1190307-88-0) Production
3.4.1 North America Sofosbuvir (CAS 1190307-88-0) Production Growth Rate (2016-2021)
3.4.2 North America Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Sofosbuvir (CAS 1190307-88-0) Production
3.5.1 Europe Sofosbuvir (CAS 1190307-88-0) Production Growth Rate (2016-2021)
3.5.2 Europe Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 China Sofosbuvir (CAS 1190307-88-0) Production
3.6.1 China Sofosbuvir (CAS 1190307-88-0) Production Growth Rate (2016-2021)
3.6.2 China Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Japan Sofosbuvir (CAS 1190307-88-0) Production
3.7.1 Japan Sofosbuvir (CAS 1190307-88-0) Production Growth Rate (2016-2021)
3.7.2 Japan Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Region
4.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Region
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Region
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Region
4.2 North America
4.2.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Sofosbuvir (CAS 1190307-88-0) Consumption by Country
4.5.2 Mexico
4.5.3 Brazil

5 Production, Revenue, Price Trend by Type
5.1 Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Type (2016-2021)
5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2016-2021)
5.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2021)

6 Consumption Analysis by Application
6.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2016-2021)
6.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.1.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2 DONG BANG FUTURE TECH & LIFE CO., LTD
7.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Main Business and Markets Served
7.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments/Updates
7.3 Beaukev Pharma International Pvt.Ltd
7.3.1 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.3.4 Beaukev Pharma International Pvt.Ltd Main Business and Markets Served
7.3.5 Beaukev Pharma International Pvt.Ltd Recent Developments/Updates
7.4 DEAFARMA
7.4.1 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.4.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.4.4 DEAFARMA Main Business and Markets Served
7.4.5 DEAFARMA Recent Developments/Updates
7.5 Tecoland
7.5.1 Tecoland Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.5.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.5.4 Tecoland Main Business and Markets Served
7.5.5 Tecoland Recent Developments/Updates
7.6 Anhui HaiKang Pharmaceutical Co. Ltd
7.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Main Business and Markets Served
7.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments/Updates
7.7 Shanghai Haoyuan Chemexpress Co., Ltd
7.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Main Business and Markets Served
7.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments/Updates
7.8 Beijing Kawin Technology Share-holding Co
7.8.1 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.8.4 Beijing Kawin Technology Share-holding Co Main Business and Markets Served
7.7.5 Beijing Kawin Technology Share-holding Co Recent Developments/Updates
7.9 Hangzhou Longshine Bio-Tech Co
7.9.1 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Corporation Information
7.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Portfolio
7.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.9.4 Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
7.9.5 Hangzhou Longshine Bio-Tech Co Recent Developments/Updates

8 Sofosbuvir (CAS 1190307-88-0) Manufacturing Cost Analysis
8.1 Sofosbuvir (CAS 1190307-88-0) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
8.4 Sofosbuvir (CAS 1190307-88-0) Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Sofosbuvir (CAS 1190307-88-0) Distributors List
9.3 Sofosbuvir (CAS 1190307-88-0) Customers

10 Market Dynamics
10.1 Sofosbuvir (CAS 1190307-88-0) Industry Trends
10.2 Sofosbuvir (CAS 1190307-88-0) Growth Drivers
10.3 Sofosbuvir (CAS 1190307-88-0) Market Challenges
10.4 Sofosbuvir (CAS 1190307-88-0) Market Restraints

11 Production and Supply Forecast
11.1 Global Forecasted Production of Sofosbuvir (CAS 1190307-88-0) by Region (2022-2027)
11.2 North America Sofosbuvir (CAS 1190307-88-0) Production, Revenue Forecast (2022-2027)
11.3 Europe Sofosbuvir (CAS 1190307-88-0) Production, Revenue Forecast (2022-2027)
11.4 China Sofosbuvir (CAS 1190307-88-0) Production, Revenue Forecast (2022-2027)
11.5 Japan Sofosbuvir (CAS 1190307-88-0) Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Sofosbuvir (CAS 1190307-88-0)
12.2 North America Forecasted Consumption of Sofosbuvir (CAS 1190307-88-0) by Country
12.3 Europe Market Forecasted Consumption of Sofosbuvir (CAS 1190307-88-0) by Country
12.4 Asia Pacific Market Forecasted Consumption of Sofosbuvir (CAS 1190307-88-0) by Region
12.5 Latin America Forecasted Consumption of Sofosbuvir (CAS 1190307-88-0) by Country
13 Forecast by Type and by Application (2022-2027)
13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
13.1.1 Global Forecasted Production of Sofosbuvir (CAS 1190307-88-0) by Type (2022-2027)
13.1.2 Global Forecasted Revenue of Sofosbuvir (CAS 1190307-88-0) by Type (2022-2027)
13.1.3 Global Forecasted Price of Sofosbuvir (CAS 1190307-88-0) by Type (2022-2027)
13.2 Global Forecasted Consumption of Sofosbuvir (CAS 1190307-88-0) by Application (2022-2027)
14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type (MT) & (US$ Million) (2021 VS 2027)
Table 2. Global Sofosbuvir (CAS 1190307-88-0) Consumption (MT) Comparison by Application: 2016 VS 2021 VS 2027
Table 3. Sofosbuvir (CAS 1190307-88-0) Market Size Comparison by Region: 2016 VS 2021 VS 2027
Table 4. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT) by Manufacturers
Table 5. Global Sofosbuvir (CAS 1190307-88-0) Production (MT) by Manufacturers (2016-2021)
Table 6. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Manufacturers (2016-2021)
Table 7. Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2016-2021)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2020)
Table 10. Global Market Sofosbuvir (CAS 1190307-88-0) Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 11. Manufacturers Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
Table 12. Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Types
Table 13. Mergers & Acquisitions, Expansion
Table 14. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT) by Region (2016-2021)
Table 15. Global Sofosbuvir (CAS 1190307-88-0) Production (MT) by Region (2016-2021)
Table 16. Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) by Region (2016-2021)
Table 17. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2016-2021)
Table 18. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 19. North America Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 20. Europe Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 21. China Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 22. Japan Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 23. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market by Region (2016-2021) & (MT)
Table 24. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Region (2016-2021)
Table 25. North America Sofosbuvir (CAS 1190307-88-0) Consumption by Country (2016-2021) & (MT)
Table 26. Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Country (2016-2021) & (MT)
Table 27. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Region (2016-2021) & (MT)
Table 28. Latin America Sofosbuvir (CAS 1190307-88-0) Consumption by Countries (2016-2021) & (MT)
Table 29. Global Sofosbuvir (CAS 1190307-88-0) Production (MT) by Type (2016-2021)
Table 30. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Type (2016-2021)
Table 31. Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) by Type (2016-2021)
Table 32. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2016-2021)
Table 33. Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT) by Type (2016-2021)
Table 34. Global Sofosbuvir (CAS 1190307-88-0) Consumption by Application (2016-2021) & (MT)
Table 35. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2016-2021)
Table 36. Global Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate by Application (2016-2021)
Table 37. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 38. Teva Pharmaceutical Industries Ltd Specification and Application
Table 39. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 40. Teva Pharmaceutical Industries Ltd Main Business and Markets Served
Table 41. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 42. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 43. DONG BANG FUTURE TECH & LIFE CO., LTD Specification and Application
Table 44. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 45. DONG BANG FUTURE TECH & LIFE CO., LTD Main Business and Markets Served
Table 46. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments/Updates
Table 47. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 48. Beaukev Pharma International Pvt.Ltd Specification and Application
Table 49. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 50. Beaukev Pharma International Pvt.Ltd Main Business and Markets Served
Table 51. Beaukev Pharma International Pvt.Ltd Recent Developments/Updates
Table 52. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 53. DEAFARMA Specification and Application
Table 54. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 55. DEAFARMA Main Business and Markets Served
Table 56. DEAFARMA Recent Developments/Updates
Table 57. Tecoland Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 58. Tecoland Specification and Application
Table 59. Tecoland Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 60. Tecoland Main Business and Markets Served
Table 61. Tecoland Recent Developments/Updates
Table 62. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 63. Anhui HaiKang Pharmaceutical Co. Ltd Specification and Application
Table 64. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 65. Anhui HaiKang Pharmaceutical Co. Ltd Main Business and Markets Served
Table 66. Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments/Updates
Table 67. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 68. Shanghai Haoyuan Chemexpress Co., Ltd Specification and Application
Table 69. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 70. Shanghai Haoyuan Chemexpress Co., Ltd Main Business and Markets Served
Table 71. Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments/Updates
Table 72. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 73. Beijing Kawin Technology Share-holding Co Specification and Application
Table 74. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 75. Beijing Kawin Technology Share-holding Co Main Business and Markets Served
Table 76. Beijing Kawin Technology Share-holding Co Recent Developments/Updates
Table 77. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Corporation Information
Table 78. Hangzhou Longshine Bio-Tech Co Specification and Application
Table 79. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 80. Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
Table 81. Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
Table 82. Production Base and Market Concentration Rate of Raw Material
Table 83. Key Suppliers of Raw Materials
Table 84. Sofosbuvir (CAS 1190307-88-0) Distributors List
Table 85. Sofosbuvir (CAS 1190307-88-0) Customers List
Table 86. Sofosbuvir (CAS 1190307-88-0) Market Trends
Table 87. Sofosbuvir (CAS 1190307-88-0) Growth Drivers
Table 88. Sofosbuvir (CAS 1190307-88-0) Market Challenges
Table 89. Sofosbuvir (CAS 1190307-88-0) Market Restraints
Table 90. Global Sofosbuvir (CAS 1190307-88-0) Production (MT) Forecast by Region (2022-2027)
Table 91. North America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country (2022-2027) & (MT)
Table 92. Europe Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country (2022-2027) & (MT)
Table 93. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Region (2022-2027) & (MT)
Table 94. Latin America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country (2022-2027) & (MT)
Table 95. Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Type (2022-2027) & (MT)
Table 96. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 97. Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Type (2022-2027) & (USD/MT)
Table 98. Global Sofosbuvir (CAS 1190307-88-0) Consumption (MT) Forecast by Application (2022-2027)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sofosbuvir (CAS 1190307-88-0)
Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Type: 2020 VS 2027
Figure 3. Purity ≥ 98% Product Picture
Figure 4. Purity ＜ 98% Product Picture
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Application: 2020 VS 2027
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) (2016-2027)
Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT) & (2016-2027)
Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Production (MT) & (2016-2027)
Figure 12. North America Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 13. Europe Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 14. China Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 15. Japan Sofosbuvir (CAS 1190307-88-0) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 16. Sofosbuvir (CAS 1190307-88-0) Production Share by Manufacturers in 2020
Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers in 2020
Figure 18. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 19. Global Market Sofosbuvir (CAS 1190307-88-0) Average Price (USD/MT) of Key Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Players: Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2020
Figure 21. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region (2016-2021)
Figure 22. North America Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate (2016-2021)
Figure 23. Europe Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate (2016-2021)
Figure 24. China Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate (2016-2021)
Figure 25. Japan Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate (2016-2021)
Figure 26. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Region (2016-2021)
Figure 27. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Region in 2020
Figure 28. North America Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 29. North America Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Country in 2020
Figure 30. Canada Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate (2016-2021) & (MT)
Figure 31. U.S. Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate (2016-2021) & (MT)
Figure 32. Europe Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate (2016-2021) & (MT)
Figure 33. Europe Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Country in 2020
Figure 34. Germany America Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 35. France Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 36. U.K. Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 37. Italy Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 38. Russia Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 39. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 40. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Regions in 2020
Figure 41. China Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 42. Japan Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 43. South Korea Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 44. Taiwan Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 45. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 46. India Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 47. Australia Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 48. Latin America Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 49. Latin America Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Country in 2020
Figure 50. Mexico Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 51. Brazil Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2016-2021) & (MT)
Figure 52. Production Market Share of Sofosbuvir (CAS 1190307-88-0) by Type (2016-2021)
Figure 53. Production Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2020
Figure 54. Revenue Share of Sofosbuvir (CAS 1190307-88-0) by Type (2016-2021)
Figure 55. Revenue Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2020
Figure 56. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2016-2021)
Figure 57. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application in 2020
Figure 58. Global Sofosbuvir (CAS 1190307-88-0) Consumption Growth Rate by Application (2016-2021)
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Sofosbuvir (CAS 1190307-88-0)
Figure 61. Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
Figure 62. Sofosbuvir (CAS 1190307-88-0) Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share Forecast by Region (2022-2027)
Figure 66. North America Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate Forecast (2022-2027)
Figure 67. Europe Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate Forecast (2022-2027)
Figure 68. China Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate Forecast (2022-2027)
Figure 69. Japan Sofosbuvir (CAS 1190307-88-0) Production (MT) Growth Rate Forecast (2022-2027)
Figure 70. Global Forecasted Demand Analysis of Sofosbuvir (CAS 1190307-88-0) (2015-2027) & (MT)
Figure 71. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share Forecast by Type (2022-2027)
Figure 72. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Type (2022-2027)
Figure 73. Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Application (2022-2027)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation